Search Results

Active, currently enrolling    Who can join   

A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

Keywords: Oncology (Adult);Gastroenterology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

Keywords: Oncology (Adult); NRG-BR002; Breast Neoplasms; Dyspnea; Vomiting; Neoplasms by…
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment For Patients With Resected Head of Pancreas Adenocarcinoma

Keywords: Oncology (Adult); RTOG 0848; Adenocarcinoma; Neoplasms; Pancreatic…
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;Urology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy

Keywords: Oncology (Adult);Urology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

Keywords: Oncology (Adult);Internal Medicine;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel: the CHAARTED2 Trial

Keywords: Oncology (Adult);Urology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Melanoma Margins Trial-II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (02.18 MelMarT-II)

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 For Men With High Risk Prostate Cancer

Keywords: Oncology (Adult); RTOG 1115; adenocarcinoma of the prostate; stage I prostate…
Study Type: Clinical Trial   |  Region: California - Northern

---